Milestone Scientific: Developing a New Standard of Care in Injection Technologies
Apr. 29, 2021
Milestone Scientific (NYSE American: MLSS) is a leading medical research and development company that designs and patents innovative injection technology. The Company’s clinically validated, patented, computer-controlled systems make injections precise, efficient, and virtually painless, addressing unmet needs and providing a potential new standard of care in anesthesia. Backed by nine peer-reviewed published studies, the Company’s CompuFlo technology addresses epidural placement failures. Epidural procedures are one of the fastest growing procedures globally with an estimated 11+ million epidural procedures performed annually in U.S. and 30+ million worldwide. U.S. and international sales channels buildout is ongoing and supported by a definitive economic study completed at the University of Texas demonstrating cost-savings versus current standard of care. MLSS reported revenue of $5.4 million in 2020. Q4 2020 revenue increased 78% sequentially over Q3 2020.
